SyntekaBio (226330.KQ) Stock Price
SyntekaBio Price
Over the last 8 years SyntekaBio grew revenue by 72.6% annually, reaching 3.43 B KRW. For SyntekaBio, the net margin of -506.8% is up versus -4,674.7% a few years ago.
SyntekaBio stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SyntekaBio business model & stock analysis
Frequently asked questions about SyntekaBio
Converted at the current exchange rate, the SyntekaBio share trades at 0.66 EUR (992.00 KRW).
The expected revenue of SyntekaBio is 7.70 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of SyntekaBio is -2.92 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of SyntekaBio is currently -8.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SyntekaBio stock.
The price-to-sales ratio (P/S) of SyntekaBio is currently 3.13. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the SyntekaBio stock.
The Eulerpool Quality Score for SyntekaBio is 3/10.
The ISIN of SyntekaBio is KR7226330009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of SyntekaBio is 226330.KQ. The ticker symbol is used to trade SyntekaBio shares on the stock exchange.
SyntekaBio stock
SyntekaBio Peer Group
SyntekaBio FIGI
All fundamentals and in-depth analysis of SyntekaBio
Our stock analysis for SyntekaBio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SyntekaBio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.